Moody National Bank Trust Division Biogen Inc. Transaction History

Moody National Bank Trust Division

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 12, 2023	BUY	$253.3 - $285.89 $13,678 - $15,438	54 Added 3.77%	1,485 $381,000
Q3 2022 Oct 05, 2022	BUY	$194.69 - $268.46 $11,486 - $15,839	59 Added 4.3%	1,431 $382,000
Q2 2022 Jul 07, 2022	BUY	$187.54 - $223.02 $257,304 - $305,983	1,372 New	1,372 $280,000
Q2 2019 Jul 22, 2019	SELL	$219.29 - $241.72 $29,823 - $32,873	-136 Closed	0 $0
Q4 2018 Jan 07, 2019	BUY	$278.5 - $352.75 $37,876 - $47,974	136 New	136 $41,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Moody National Bank Trust Division, based on Form 13F filings with the SEC.

Stay updated on Moody National Bank Trust Division with notifications on news.